Skip to content
10-Q

Quarterly Report

JRSIS HEALTH CARE CORPORATION JRSS

0001213900-23-069101

← back to feed
Filed
Aug 21, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 21, 2023 5.84M sh
Cash And Equivalents Q2 2023 · Jun 30, 2023 $28.22K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $58.62K
Stockholders Equity Q2 2023 · Jun 30, 2023 $591.99K
Stockholders Equity Q2 2023 · Mar 31, 2023 $691.9K
Stockholders Equity Q2 2023 · Dec 31, 2022 $811.32K
Stockholders Equity Q2 2023 · Jun 30, 2022 $989.5K
Stockholders Equity Q2 2023 · Mar 31, 2022 $35.95M
Stockholders Equity restated Q2 2023 · Dec 31, 2021 $33.1M
Current Liabilities Q2 2023 · Jun 30, 2023 $69.39K
Current Liabilities Q2 2023 · Dec 31, 2022 $43.23K
Total Liabilities Q2 2023 · Jun 30, 2023 $69.39K
Total Liabilities Q2 2023 · Dec 31, 2022 $44.66K
Current Assets Q2 2023 · Jun 30, 2023 $617.6K
Current Assets Q2 2023 · Dec 31, 2022 $798.85K
Total Assets Q2 2023 · Jun 30, 2023 $661.38K
Total Assets Q2 2023 · Dec 31, 2022 $855.98K
Shares Diluted restated Q2 2023 · Jun 30, 2022 4.39M sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 3.13M sh
Capex Q2 2023 · Jun 30, 2022 $44.52K
Operating Cash Flow restated Q2 2023 · Jun 30, 2022 $3.03M
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$8.25
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$10.73
Eps Basic restated Q2 2023 · Jun 30, 2022 −$8.25
Eps Basic restated Q2 2023 · Jun 30, 2022 −$10.73
Net Income restated Q2 2023 · Jun 30, 2022 −$36.18M
Net Income Q2 2023 · Jun 30, 2022 −$33.54M
Operating Income Q2 2023 · Jun 30, 2022 −$127.29K
Operating Income Q2 2023 · Jun 30, 2022 −$149.61K